Wilbert Van Duijnhoven
Antwerpen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial.
Journal: Inflammatory bowel diseases
Published: December 18, 2025
Prophylactic Efficacy of CD388, a Novel Drug-Fc Conjugate, in a Human Influenza A/H3N2 Virus Challenge Model: A Randomized, Controlled Phase 2a Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 11, 2025
A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12-24 Months.
Journal: Open forum infectious diseases
Published: June 20, 2024
Efficacy and Safety of Pimodivir Combined With Standard of Care in Hospitalized and Nonhospitalized High-Risk Adolescents and Adults With Influenza A Infection.
Journal: The Journal of infectious diseases
Published: March 06, 2024
Genotypic and phenotypic characterization of influenza A viral variants in study participants treated with pimodivir in the phase 2b TOPAZ study.
Journal: Antiviral therapy
Published: May 25, 2023
The Hospital Recovery Scale: A clinically useful endpoint in patients hospitalized with influenza.
Journal: Contemporary clinical trials
Published: June 30, 2022
A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study.
Journal: The Journal of infectious diseases
Published: January 09, 2020
Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial.
Journal: The Journal of infectious diseases
Published: May 08, 2018
Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.
Journal: JAMA
Published: April 20, 2016
Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
Journal: Vaccine
Published: January 22, 2014
Meta-analyses of the efficacy of asenapine for acute schizophrenia: comparisons with placebo and other antipsychotics.
Journal: The Journal of clinical psychiatry
Published: December 09, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026